Outcome of medulloblastoma in children treated with reduced-dose radiation therapy plus adjuvant chemotherapy

• Main Authors: Nongnuch Sirachainan, Issarang Nuchprayoon, Pattra Thanarattanakorn, Samart Pakakasama, Apasri Lusawat, Anannit Visudibhan, Mantana Dhanachai, Noppadol Larbcharoensub, Jiraporn Amornfa, Kanchana Shotelersuk, Kamornwan Katanyuwong, Saipin Tangkaratt, Suradej Hongeng
• Other Authors: Mahidol University
• Format: Article
• Published: 2018
• Subjects: Medicine; Neuroscience
• Online Access: https://repository.li.mahidol.ac.th/handle/123456789/12582

Medulloblastoma is the most common malignant brain tumor in children. Post-surgical craniospinal irradiation (CSI; 30-36 Gy) plus local boost radiation therapy (RT; 54-56 Gy) is a standard treatment for children with medulloblastoma who are over 3 years old, resulting in a 5-year overall survival (O...